Apellis Pharmaceuticals (APLS) Buy Rating Reiterated at HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) Director Alec Machiels sold 1,250 shares of the firm’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $64.79, for a total transaction of $80,987.50. Following the sale, the director now owns 267,641 shares in the company, valued at […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $84.55, for a total value of $1,014,600.00. Following the completion of the transaction, the insider now owns 1,046,813 shares in the […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) CFO Timothy Eugene Sullivan sold 6,779 shares of Apellis Pharmaceuticals stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $89.97, for a total transaction of $609,906.63. Following the completion of the transaction, the chief financial officer now directly owns 77,713 […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) General Counsel David O. Watson sold 8,510 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $89.98, for a total value of $765,729.80. Following the completion of the transaction, the general counsel now owns 85,753 shares […]